Austedo 12 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FS5ZC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,160
Award facts
- Contract value 100% obligated
- $23,159.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $23,159.64 to AmerisourceBergen Drug Corp for the supply of Austedo 12 mg tablets (60-count packages) on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed-price, non-set-aside contract was competitively awarded and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Austedo is a FDA-approved medication used to treat involuntary movement disorders, reflecting the Defense Logistics Agency's ongoing procurement of specialized pharmaceutical products to support military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen Drug Corp maintains an extensive portfolio of federal contract awards with the Defense Logistics Agency's Medical Supply Chain, serving customers including the Defense Health Agency and U.S. Coast Guard across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FS5ZC?
SPE2DB25FS5ZC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 29, 2025.
How much is contract SPE2DB25FS5ZC worth?
The government has obligated $23,160 on SPE2DB25FS5ZC.
Is contract SPE2DB25FS5ZC an order under another contract?
Yes. SPE2DB25FS5ZC is a delivery order under SPE2DB22D2214, an indefinite delivery contract.
Was contract SPE2DB25FS5ZC competed?
The extent of competition for SPE2DB25FS5ZC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award